- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
VCI Wealth Management LLC Buys Stake in AbbVie Inc.
The investment firm added over 12,000 shares of the pharmaceutical company in Q4 2025.
Apr. 19, 2026 at 2:04pm
Got story updates? Submit your updates here. ›
The complex machinery and infrastructure behind AbbVie's pharmaceutical production highlights the company's industrial scale and technical expertise.North Chicago TodayVCI Wealth Management LLC disclosed in a recent SEC filing that it bought a new position in AbbVie Inc. (NYSE: ABBV) during the fourth quarter of 2025. The firm purchased 12,008 shares of the pharmaceutical company's stock, valued at approximately $2.74 million.
Why it matters
AbbVie is a major player in the pharmaceutical industry, with a diverse portfolio of drugs across several therapeutic areas. The company's stock performance and institutional investment activity are closely watched by analysts and investors.
The details
According to the filing, VCI Wealth Management's new position in AbbVie represents a strategic investment in the company. AbbVie's stock has seen fluctuations in recent quarters, with the share price ranging from a 52-week low of $168.54 to a high of $244.81.
- VCI Wealth Management LLC bought the AbbVie shares in the fourth quarter of 2025.
- AbbVie's stock price ranged from $168.54 to $244.81 over the past 52 weeks.
The players
VCI Wealth Management LLC
An investment management firm that recently purchased a new position in AbbVie Inc.
AbbVie Inc.
A global biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and chronic medical conditions.
The takeaway
The investment by VCI Wealth Management in AbbVie reflects the continued institutional interest in the pharmaceutical company's stock, despite some recent volatility in the share price. As a major player in the industry, AbbVie's performance and strategic moves will likely continue to be closely watched by analysts and investors.
